Cargando…
An Autologous Anti-Inflammatory Protein Solution Yielded a Favorable Safety Profile and Significant Pain Relief in an Open-Label Pilot Study of Patients with Osteoarthritis
Osteoarthritis (OA) is a progressive and degenerative disease, which may result in significant pain and decreased quality of life. Recent updates in our understanding of OA have demonstrated that it is a whole joint disease that has many similarities to an unhealed wound containing inflammatory cyto...
Autores principales: | Hix, Jason, Klaassen, Mark, Foreman, Ryan, Cullen, Edith, Toler, Krista, King, William, Woodell-May, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738995/ https://www.ncbi.nlm.nih.gov/pubmed/29279807 http://dx.doi.org/10.1089/biores.2017.0027 |
Ejemplares similares
-
Role of White Blood Cells in Blood- and Bone Marrow-Based Autologous Therapies
por: King, William, et al.
Publicado: (2018) -
White blood cell concentration correlates with increased concentrations of IL-1ra and improvement in WOMAC pain scores in an open-label safety study of autologous protein solution
por: King, William, et al.
Publicado: (2016) -
Safety and Treatment Effectiveness of a Single Autologous Protein Solution Injection in Patients with Knee Osteoarthritis
por: van Drumpt, Rogier A.M., et al.
Publicado: (2016) -
Potential Mechanism of Action of Current Point-of-Care Autologous Therapy Treatments for Osteoarthritis of the Knee—A Narrative Review
por: Woodell-May, Jennifer, et al.
Publicado: (2021) -
Autologous protein solution: a promising solution for osteoarthritis?
por: Bin Abd Razak, Hamid Rahmatullah, et al.
Publicado: (2021)